Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 6;116(7):655-662.
doi: 10.1093/trstmh/trab189.

Molecular characterisation of carbapenem-resistant Klebsiella pneumoniae clinical isolates: preliminary experience from a tertiary care teaching hospital in the Himalayas

Affiliations

Molecular characterisation of carbapenem-resistant Klebsiella pneumoniae clinical isolates: preliminary experience from a tertiary care teaching hospital in the Himalayas

Mohit Bhatia et al. Trans R Soc Trop Med Hyg. .

Abstract

Background: There is a lack of whole-genome sequencing (WGS) data on multidrug-resistant (MDR) bacteria from the Uttarakhand region of India. The aim of this study was to generate WGS data of carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates recovered from patients in Uttarakhand's tertiary care centre.

Methods: A cross-sectional study included 29 MDR K. pneumoniae test isolates obtained from various clinical samples submitted to the bacteriology laboratory for culture and sensitivity testing from July 2018 to August 2019. After preliminary identification and antibiotic susceptibility testing, these isolates were subjected to WGS.

Results: A total of 27 of 29 isolates were CRKP. ST14 was the most common sequence type (n=8 [29.6%]). Carbapenem resistance was mainly encoded by OXA-48-like genes (21/27 [77.8%]). All isolates had a varied arsenal of resistance genes to different antibiotic classes. KL2 (9/27 [33.3%]) and KL51 (8/27 [29.6%]) were dominant K loci types. O1 and O2 together accounted for 88.9% (n=27) of CRKP isolates. Genes encoding yersiniabactin (ybt) and aerobactin (iuc) were identified in 88.9% (24/27) and 29.6% (8/27) of isolates. The predominant plasmid replicons present were ColKP3 (55.5%), IncFII(K) (51.8%) and IncFIB(pQil) (44.4%).

Conclusions: This study emphasises the need for continued genomic surveillance of MDR bacteria that could be instrumental in developing treatment guidelines based on integrating phenotypic and molecular methods.

Keywords: Klebsiella pneumoniae; carbapenem resistance; molecular characterisation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phylogeny of the 29 K. pneumoniae isolates. Midpoint-rooted phylogenetic tree obtained after mapping the genomes to the complete genome of strain K. pneumoniae (strain NZ_CP026011.1 (ST1)). The metadata blocks are arranged to show a complete overview of different resistance patterns to antibiotics, acquired virulence factors and plasmids that are present in the study. Tree nodes are coloured according to their sequence. Scale bars represent the number of single-nucleotide polymorphisms per variable site.

References

    1. Holt KE, Wertheim H, Zadoks RNet al. . Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci USA. 2015;112(27):E3574–81. - PMC - PubMed
    1. Dumitru IM, Dumitrascu M, Vlad NDet al. . Carbapenem-resistant Klebsiella pneumoniae associated with COVID-19. Antibiotics. 2021;10(5):561. - PMC - PubMed
    1. Elshamy AA, Aboshanab KM.. A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Sci OA. 2020;6(3):FSO438. - PMC - PubMed
    1. Poirel L, Jayol A, Nordmann P.. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–96. - PMC - PubMed
    1. Karakonstantis S, Kritsotakis EI, Gikas A.. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection. 2020;48(6):835–51. - PMC - PubMed

Publication types

MeSH terms